| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...737960Y |
| P356 | DOI | 10.1371/JOURNAL.PONE.0037960 |
| P932 | PMC publication ID | 3360669 |
| P698 | PubMed publication ID | 22662257 |
| P5875 | ResearchGate publication ID | 225098294 |
| P50 | author | Yong-Yu Liu | Q38546585 |
| P2093 | author name string | Yi Ren | |
| Zhen Li | |||
| Yao Li | |||
| Yi-Xue Xue | |||
| Cheng-Liang Yang | |||
| Ye-Gang Ma | |||
| Xiao-Bai Liu | |||
| De-Gui Liu | |||
| P2860 | cites work | Lung cancer | Q73858423 |
| Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells | Q74200546 | ||
| Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma | Q80228054 | ||
| Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas | Q24669579 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Nuclear transcription factor-kappaB as a target for cancer drug development | Q28201984 | ||
| STATs and gene regulation | Q29547796 | ||
| A novel target for treatment of chordoma: signal transducers and activators of transcription 3. | Q33273492 | ||
| Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer | Q33448971 | ||
| The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors | Q33613105 | ||
| Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis | Q33900139 | ||
| Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? | Q35557450 | ||
| Cancer risk and diet in India | Q35575541 | ||
| Role of chemopreventive agents in cancer therapy | Q35920265 | ||
| Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines | Q36070435 | ||
| Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting | Q36175369 | ||
| Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. | Q36300062 | ||
| STAT3 as a central mediator of neoplastic cellular transformation | Q36665485 | ||
| Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications | Q36749049 | ||
| Molecular approaches towards the inhibition of the signal transducer and activator of transcription 3 (Stat3) protein | Q37015696 | ||
| Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells | Q37385705 | ||
| Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3 | Q37437236 | ||
| Bioactive natural products derived from the East African flora | Q37638288 | ||
| Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells | Q38353138 | ||
| Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway | Q39516612 | ||
| Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. | Q39726725 | ||
| Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators | Q39933616 | ||
| Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells | Q40366043 | ||
| Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer | Q42277237 | ||
| Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines. | Q44183141 | ||
| Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation | Q44250309 | ||
| Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. | Q44727251 | ||
| Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1,2 dimethylhydrazine-induced colon cancer | Q46599915 | ||
| Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer | Q46831080 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell migration | Q189092 |
| curcumin | Q312266 | ||
| angiogenesis | Q539568 | ||
| lung cancer | Q47912 | ||
| P304 | page(s) | e37960 | |
| P577 | publication date | 2012-05-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway | |
| P478 | volume | 7 |
| Q38764893 | A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer |
| Q38383263 | A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer |
| Q39121242 | A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells. |
| Q64924502 | ANIMAL MODELS FOR COLORECTAL CANCER. |
| Q38779446 | Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways |
| Q37587398 | Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium |
| Q39044440 | Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies |
| Q26774897 | Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results |
| Q38660081 | Antitumor effects of curcumin in human bladder cancer in vitro |
| Q37513440 | Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer |
| Q28543608 | Astaxanthin inhibits JAK/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancer |
| Q36334519 | Biological and therapeutic activities, and anticancer properties of curcumin |
| Q27002903 | Broad targeting of angiogenesis for cancer prevention and therapy |
| Q36842067 | C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis |
| Q26860058 | Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control |
| Q26738714 | Curcumin AntiCancer Studies in Pancreatic Cancer |
| Q49423558 | Curcumin Inhibits Growth of Human NCI-H292 Lung Squamous Cell Carcinoma Cells by Increasing FOXA2 Expression |
| Q35692600 | Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function |
| Q26765493 | Curcumin and Health |
| Q38212780 | Curcumin and lung cancer--a review |
| Q37266391 | Curcumin cytotoxicity is enhanced by PTEN disruption in colorectal cancer cells |
| Q34672128 | Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway |
| Q38697407 | Curcumin inhibits bladder cancer progression via regulation of β-catenin expression |
| Q37071565 | Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells |
| Q34672640 | Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway |
| Q38798056 | Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway |
| Q38940152 | Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways |
| Q38921106 | Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1. |
| Q54936059 | Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. |
| Q39069500 | Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo. |
| Q38501499 | Curcumin, inflammation, and chronic diseases: how are they linked? |
| Q38836327 | Curcumisome nanovesicles generated by self-assembly of curcumin amphiphiles toward cancer theranostics |
| Q89909542 | Development of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: Validation and stability |
| Q38622264 | Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits? |
| Q35535937 | Dietary agents for prevention and treatment of lung cancer |
| Q51048899 | Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening. |
| Q90217697 | Evaluation of Interleukin-6, Leukotriene B-4, and Nitric Oxide Levels in Exhaled Breath Condensate of Asymptomatic Obese Individuals: Are Obese Patients Under Risk of Developing Asthma? |
| Q28649395 | Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer |
| Q38432455 | Identification of curcumin-inhibited extracellular matrix receptors in non-small cell lung cancer A549 cells by RNA sequencing |
| Q38960718 | Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells |
| Q38837342 | Inhibition of lung cancer cells A549 and H460 by curcuminoid extracts and nanoemulsions prepared from Curcuma longa Linnaeus |
| Q59129787 | Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models |
| Q92767389 | Long noncoding RNA PART1 promotes progression of non-small cell lung cancer cells via JAK-STAT signaling pathway |
| Q28535183 | Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer |
| Q91814938 | Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer |
| Q39051513 | MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells |
| Q37590102 | Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties |
| Q48160819 | N-Acetyl-tryptophan glucoside (NATG) protects J774A.1 murine macrophages against gamma radiation-induced cell death by modulating oxidative stress. |
| Q38823905 | N-acetyl tryptophan glucopyranoside (NATG) provides radioprotection to murine macrophage J774A.1 cells |
| Q38724921 | Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma. |
| Q38235327 | Natural products and their derivatives regulating the janus kinase/signal transducer and activator of transcription pathway |
| Q39264505 | Osteosarcoma cells induce endothelial cell proliferation during neo-angiogenesis |
| Q30405870 | PIAS3 expression in squamous cell lung cancer is low and predicts overall survival |
| Q64083504 | Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, , Green Tea and Coffee Properties |
| Q92928274 | Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs |
| Q42282831 | Potential anti-cancer effect of curcumin in human lung squamous cell carcinoma |
| Q87353059 | Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers |
| Q38525432 | Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art |
| Q39170256 | Pulmonary delivery systems for polyphenols |
| Q45948898 | Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. |
| Q34646174 | Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells |
| Q35628368 | SOCS3 blocks HIF-1α expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3 |
| Q90094368 | Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer |
| Q40729879 | Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease |
| Q34783126 | Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway |
| Q43161193 | Spicing up endogenous neural stem cells: aromatic-turmerone offers new possibilities for tackling neurodegeneration |
| Q58760963 | Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites |
| Q39138948 | Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a. |
| Q37292721 | Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle |
| Q26750725 | Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease |
| Q37412314 | The Janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo |
| Q38203779 | The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer |
| Q55629415 | The Role of Curcumin in Prevention and Management of Metastatic Disease. |
| Q34667865 | The multifaceted role of curcumin in cancer prevention and treatment. |
| Q33948351 | Therapeutic applications of curcumin for patients with pancreatic cancer |
| Q33684732 | Therapeutic modulators of STAT signalling for human diseases |
| Q38891828 | Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway. |
| Q28073155 | Unraveling the Anticancer Effect of Curcumin and Resveratrol |
| Q38823195 | W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. |
| Q28538995 | pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1) |
Search more.